REICHENBACHER, KATHARINA,DUGUID, ROBERT J.,SIMSON, JACQUELINE A.,PHILLIPSON, DOUGLAS
申请号：
PE0014332011
公开号：
PE05852012A1
申请日:
2010.02.03
申请国别(地区):
PE
年份:
2012
代理人:
摘要：
Referring to a Crystalline Compound di hydrogen phosphate, Purified (R) - 3 - (4 - (2 - (5 - metiltetrazol - il) pyridin - 5 - il) - 3 - (4-fluorophenyl) - 5 - Hydroxymethyl oxazolidin - 2 - One, characterized by a purity of at least 96 - 97% by weight and shows a pattern with endothermic DSC Peaks approximately 255 - 258C. Also referred to a Pharmaceutical composition.The Glass is useful in the treatment of bacterial infectionsREFERIDA A UN COMPUESTO FOSFATO DE DI-HIDROGENO CRISTALINO, PURIFICADO (R)-3-(4-(2-(2-METILTETRAZOL-5-IL)PIRIDIN-5-IL)-3-FLUOROFENIL)-5-HIDROXIMETIL OXAZOLIDIN-2-ONA, CARACTERIZADO POR UNA PUREZA DE AL MENOS 96-97% EN PESO Y MUESTRA UN PATRON DSC CON PICOS ENDOTERMICOS DE APROXIMADAMENTE 255-258C. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHO CRISTAL ES UTIL EN EL TRATAMIENTO DE INFECCIONES BACTERIALES
